Progyny, Inc.

Valuation Analysis

About the Company

Progyny, Inc. en bref

Progyny, Inc. (PGNY) is currently trading at 22,76 € with a market capitalization of 1,8 Md €. The trailing P/E ratio stands at 33.87x, with a forward P/E of 11.82x. The 52-week range spans from 14,05 € to 25,09 €; the current price is 9.3% below the yearly high. Year-over-year revenue growth stands at +1.4%. The net profit margin stands at 5.24%.

💰 Dividende

Progyny, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

11 analystes évaluent Progyny, Inc. (PGNY) au consensus : Achat Fort. L'objectif de cours moyen est de 25,94 €, soit un potentiel de +13.98% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 22,69 € à 27,05 €.

Progyny, Inc. : la thèse d'investissement en détail

Progyny, Inc. (PGNY) operates in the Healthcare — specifically Healthcare Plans — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Earnings growth of 70.6% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base.

Le scénario baissier

Revenue growth has slowed to just 1.4%, which is below nominal GDP — the business is no longer outgrowing the broader economy. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

À surveiller

• The forward P/E of 11.82x is meaningfully below the trailing 33.87x — analysts expect earnings to step up; the next earnings release is the test.

Thèse d'investissement : forces et faiblesses

Aperçu technique

The price is in a transition zone relative to the moving averages — no clear signal.

Profil de risque

The data points to market-like volatility, elevated short interest (9.09%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Progyny, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.